These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24191973)

  • 1. Using measurement strategies to identify and monitor residual symptoms.
    McIntyre RS
    J Clin Psychiatry; 2013; 74 Suppl 2():14-8. PubMed ID: 24191973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice.
    Papakostas GI
    J Clin Psychiatry; 2014 Jan; 75(1):8-14. PubMed ID: 24345473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence, measurement, and treatment of the cognitive dimension/domain in major depressive disorder.
    McIntyre RS; Xiao HX; Syeda K; Vinberg M; Carvalho AF; Mansur RB; Maruschak N; Cha DS
    CNS Drugs; 2015 Jul; 29(7):577-89. PubMed ID: 26290264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.
    Bortolato B; Carvalho AF; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 14():30-4. PubMed ID: 14658933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring cognitive function in MDD: emerging assessment tools.
    Russo M; Mahon K; Burdick KE
    Depress Anxiety; 2015 Apr; 32(4):262-9. PubMed ID: 25421437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in major depressive disorder.
    Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS
    CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian psychiatrists' perception on cognitive symptoms in major depressive disorder.
    Albert U; Brugnoli R; Caraci F; Dell'Osso B; Di Sciascio G; Tortorella A; Vampini C; Cataldo N; Pegoraro V
    Int J Psychiatry Clin Pract; 2016; 20(1):2-9. PubMed ID: 26523906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions.
    McIntyre RS; Cha DS; Soczynska JK; Woldeyohannes HO; Gallaugher LA; Kudlow P; Alsuwaidan M; Baskaran A
    Depress Anxiety; 2013 Jun; 30(6):515-27. PubMed ID: 23468126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study.
    Elgamal S; McKinnon MC; Ramakrishnan K; Joffe RT; MacQueen G
    Psychol Med; 2007 Sep; 37(9):1229-38. PubMed ID: 17610766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder.
    Stahl SM; Zhang L; Damatarca C; Grady M
    J Clin Psychiatry; 2003; 64 Suppl 14():6-17. PubMed ID: 14658930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive deficits and disability in major depressive disorder.
    Jaeger J; Berns S; Uzelac S; Davis-Conway S
    Psychiatry Res; 2006 Nov; 145(1):39-48. PubMed ID: 17045658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cognitive symptoms after a buspirone-melatonin combination treatment for Major Depressive Disorder.
    Targum SD; Wedel PC; Fava M
    J Psychiatr Res; 2015 Sep; 68():392-6. PubMed ID: 26025562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychomotor functioning in chronic fatigue syndrome and major depressive disorder: a comparative study.
    Schrijvers D; Van Den Eede F; Maas Y; Cosyns P; Hulstijn W; Sabbe BG
    J Affect Disord; 2009 May; 115(1-2):46-53. PubMed ID: 18817977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian neurologists' perception on cognitive symptoms in major depressive disorder.
    Neri G; Serrati C; Zolo P; Cataldo N; Ripellino C
    Neurol Sci; 2016 Sep; 37(9):1437-42. PubMed ID: 27155852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.
    Godard J; Grondin S; Baruch P; Lafleur MF
    Psychiatry Res; 2011 Dec; 190(2-3):244-52. PubMed ID: 21764461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.
    Goeldner C; Ballard TM; Knoflach F; Wichmann J; Gatti S; Umbricht D
    Neuropharmacology; 2013 Jan; 64():337-46. PubMed ID: 22992331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a patient-administered depression rating scale valid for detecting cognitive deficits in patients with major depressive disorder?
    Hueng TT; Lee IH; Guog YJ; Chen KC; Chen SS; Chuang SP; Yeh TL; Yang YK
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):70-6. PubMed ID: 21265938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.